ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,068Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 393

$773K Total Retail Price of All Prescriptions

Rank: 15 out of 393

341 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 341 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 341 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,358 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
WARFARIN SODIUM 812 559 1 17
RISPERIDONE 402 312 2 75
AMLODIPINE BESYLATE 389 362 3 4
LISINOPRIL 381 316 4 2
SIMVASTATIN 347 197 5 1
METOPROLOL TARTRATE 339 235 6 9
FUROSEMIDE 322 252 7 8
NAMENDA 317 295 8 59
LEVOTHYROXINE SODIUM 314 259 9 3
LEVETIRACETAM 309 164 10 112
OMEPRAZOLE 297 213 11 6
DONEPEZIL HCL 293 268 12 34
POTASSIUM CHLORIDE 271 175 13 20
HYDROCODONE-ACETAMINOPHEN 268 201 S3 14 5
GABAPENTIN 238 165 15 15
IPRATROPIUM BROMIDE 231 172 16 106
ALBUTEROL SULFATE 229 185 17 92
CITALOPRAM HBR 217 168 18 23
LEVEMIR FLEXPEN 193 147 19 117
MORPHINE SULFATE ER 188 29 S2 20 48
QUETIAPINE FUMARATE 175 113 21 104
NOVOLIN R 169 121 22 144
RANITIDINE HCL 168 124 23 29
OXYCODONE HCL 161 105 S2 24 36
HEPARIN SODIUM 159 97 25 153
BACLOFEN 155 83 26 79
JANTOVEN 153 126 27 105
METFORMIN HCL 140 86 28 7
TRAZODONE HCL 131 69 29 47
DIVALPROEX SODIUM 128 85 30 124
SANTYL 125 69 31 149
LAMOTRIGINE 125 58 31 220
CYMBALTA 125 65 31 88
NOVOLOG FLEXPEN 119 87 34 127
PANTOPRAZOLE SODIUM 115 71 35 56
CIPROFLOXACIN HCL 113 84 36 57
METOCLOPRAMIDE HCL 99 62 37 141
SODIUM CHLORIDE 98 60 38 164
HYDRALAZINE HCL 97 84 39 64
GLIPIZIDE 96 75 40 32
MIRTAZAPINE 95 52 41 89
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 50 42 111
ATORVASTATIN CALCIUM 89 69 43 19
VALPROIC ACID 88 36 44 241
LIDODERM 88 72 44 116
LANTUS 87 54 46 73
FLUOXETINE HCL 86 53 47 37
TAMSULOSIN HCL 84 62 48 25
PROTONIX 83 39 10 49 245
LOVASTATIN 82 62 50 14
CLOPIDOGREL 79 45 51 33
CARVEDILOL 78 53 52 21
HYDROMORPHONE HCL 77 60 S2 53 138
DIGOXIN 76 72 54 66
VANCOMYCIN HCL 74 33 55 171
FAMOTIDINE 73 56 56 70
DILTIAZEM HCL 72 72 57 175
LIDOCAINE HCL 70 70 58 259
SEROQUEL 69 48 59 193
HYDROCHLOROTHIAZIDE 67 49 60 10
CARBIDOPA-LEVODOPA 62 52 61 142
VIMPAT 61 0 62 201
CLONIDINE HCL 57 43 63 50
PLAVIX 57 42 63 51
METHADONE HCL 53 26 S2 65 102
OXYBUTYNIN CHLORIDE 53 39 65 90
GLYBURIDE 51 26 R 67 46
ROPINIROLE HCL 51 47 67 121
ZOLPIDEM TARTRATE 50 30 69 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.